Is XBIOW or DIVO a better dividend investment in 2026?

XBIOW currently yields 11.40% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: XBIOW offers higher current income.

What is the dividend yield difference between XBIOW and DIVO?

XBIOW has a forward dividend yield of 11.40% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 4.91 percentage points.

Home › Compare › XBIOW vs DIVO

XBIOW vs DIVO: Dividend Comparison 2026

XBIOW yields 11.40% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 XBIOW wins by $11.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

XBIOW

● Live price

11.40%

Share price

$17.54

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$42.5K

Annual income

$2,326.31

Full XBIOW calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — XBIOW vs DIVO

📍 XBIOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XBIOW	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XBIOW + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XBIOW pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XBIOW

Annual income on $10K today (after 15% tax)

$969.21/yr

After 10yr DRIP, annual income (after tax)

$1,977.36/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, XBIOW beats the other by $1,142.94/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XBIOW + DIVO for your $10,000?

XBIOW: 50%DIVO: 50%

100% DIVO50/50100% XBIOW

Portfolio after 10yr

$36.6K

Annual income

$1,654.00/yr

Blended yield

4.52%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XBIOW buys

DIVO buys

No recent congressional trades found for XBIOW or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXBIOWDIVO

Forward yield	11.40% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$42.5K ✓	$30.7K
Annual income after 10y	$2,326.31 ✓	$981.68
Total dividends collected	$17.2K ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: XBIOW vs DIVO ($10,000, DRIP)

Year	XBIOW Portfolio	XBIOW Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$11,840	$1,140.25	$11,349	$649.42	+$491.00 → XBIOW
2	$13,931	$1,261.76	$12,833	$688.83	+$1.1K → XBIOW
3	$16,293	$1,387.43	$14,459	$727.90	+$1.8K → XBIOW
4	$18,951	$1,516.57	$16,238	$766.49	+$2.7K → XBIOW
5	$21,926	$1,648.49	$18,179	$804.47	+$3.7K → XBIOW
6	$25,243	$1,782.51	$20,293	$841.71	+$5.0K → XBIOW
7	$28,928	$1,917.94	$22,591	$878.14	+$6.3K → XBIOW
8	$33,007	$2,054.14	$25,087	$913.65	+$7.9K → XBIOW
9	$37,508	$2,190.46	$27,791	$948.18	+$9.7K → XBIOW
10	$42,460	$2,326.31	$30,718	$981.68	+$11.7K → XBIOW

XBIOW vs DIVO: Complete Analysis 2026

XBIOW — Stock

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Full XBIOW Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this XBIOW vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XBIOW vs SCHD XBIOW vs JEPI XBIOW vs O XBIOW vs KO XBIOW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.